【科尔尼】2024东南亚生育危机应对策略研究报告试管婴儿IVF技术孕育希望之路_18页_2mb

Summary of Southeast Asia's Fertility Crisis and IVF Market Opportunities

Core Content

Southeast Asia (SEA) is experiencing a significant decline in fertility rates, with implications for demographic, economic, and healthcare systems. Over the past five decades, the region's fertility rate has dropped from 5.6 to 2.2 children per woman, with Singapore showing the most dramatic decline, reaching 1.0 children per woman. This trend is driven by a combination of factors, including changing family planning dynamics, urbanization, lifestyle shifts, and the increasing prevalence of health conditions like diabetes and obesity.

Main Trends and Factors

• Fertility Decline: SEA fertility rates have declined faster than the global average, contributing to aging populations and potential population shrinkage.
• Societal Shifts: Couples in upper economic classes are opting for smaller families due to career and financial priorities, while governments in developing economies promote family planning among lower-income groups.
• Lifestyle Changes: Delayed childbirth due to education and career focus is a major driver of age-related infertility.
• Health Conditions: Rising diabetes and obesity rates are negatively impacting fertility, especially in women.

IVF as a Solution

• Role of IVF: Assisted reproductive technologies (ART), particularly IVF, can address infertility issues and help couples conceive, especially those affected by age or health conditions.
• Effectiveness: While IVF can improve fertility rates for specific demographics, it is not sufficient to reverse the broader decline in birth rates.
• Market Penetration: Only about 121,000 IVF cycles are performed annually in SEA's six leading economies, indicating a low overall penetration.
• Regional Differences:
  • Nascent Markets: Indonesia and the Philippines have very low IVF penetration (<1 cycle per 1,000 women), with services primarily available to upper socioeconomic groups.
  • Maturing Markets: Thailand, Vietnam, and Malaysia are in the maturing stage, with 1–7 cycles per 1,000 women, but still face access and affordability issues.
  • Mature Markets: Singapore is the only mature market in SEA, with high IVF accessibility and success rates.

IVF Market in Southeast Asia

• Cost and Coverage:
  • Singapore has the highest per-cycle cost at $9,300, but partial public insurance coverage helps.
  • Malaysia offers unique financial options, including pension fund usage and tax relief.
  • Other countries rely on out-of-pocket payments or private insurance.
• Success Rates:
  • Singapore and Malaysia have success rates of around 50–60%, while Indonesia's lower success rate leads to higher costs per successful pregnancy.
• Regulatory Environment:
  • Thailand and Singapore allow donor use, making them attractive for medical tourism.
  • Indonesia and the Philippines lack specific IVF laws, which may hinder widespread adoption.

Patient Insights

• Awareness and Acceptability: IVF is increasingly accepted in maturing markets like Malaysia and Singapore, but stigma persists in nascent markets, especially in tier 2 and tier 3 cities.
• Barriers to Access:
  • High out-of-pocket costs are a major deterrent.
  • Limited knowledge about IVF and its legal framework reduces consideration among potential users.
  • In Muslim-majority countries like Indonesia and Malaysia, cultural and religious values can influence IVF acceptance.
• Treatment Preferences: Patients often undergo 1–3 cycles, with methods like frozen embryo transfer, intracytoplasmic sperm injection, and natural IVF being most common.

Expert Insights

• Maturing Markets:
  • IVF is becoming more accepted due to marketing efforts.
  • Areas for improvement include affordability, accessibility, and regulatory clarity.
• Nascent Markets:
  • Stigma and limited awareness are major challenges.
  • Technology can help improve affordability and success rates, but capability gaps remain.
  • Partnerships with private clinics can help expand access to tier 2 and tier 3 cities.

Areas for Improvement

• Affordability: Reducing costs and exploring alternative financing models (e.g., private insurance, family support) is crucial for expanding IVF access.
• Accessibility: Expanding clinic coverage to tier 2 and tier 3 cities is necessary to reach a broader population.
• Regulatory Clarity: Clear and transparent regulations can reduce uncertainty and support industry growth.
• Technological Integration: AI, robotics, and IoT can enhance treatment precision, reduce costs, and improve success rates.

Technology's Role in IVF Innovation

• Predictive Analytics: Helps in optimizing patient selection and tailoring treatment plans for better outcomes.
• AI: Enhances embryo selection and enables non-invasive genetic testing, increasing success rates.
• Robotics and IoT: Streamline fertility treatments, reduce human error, and improve scalability and accessibility.

Call to Action for Stakeholders

• Public Institutions: Should reduce stigma, provide fiscal incentives, and integrate IVF into public healthcare systems.
• IVF Providers: Need to expand services to underserved areas and improve affordability.
• Medical Developers and Pharmaceutical Companies: Can innovate in low-cost drug and consumable solutions.
• Payors: Should explore alternative financing models and expand insurance coverage to include IVF.

Conclusion

Southeast Asia's fertility crisis is a growing concern, with IVF emerging as a viable solution for couples facing infertility. While the region's IVF market is still in its early stages, there are clear opportunities for growth through education, affordability, and technological advancement. Strategic collaboration among stakeholders is essential to ensure equitable access and sustainable development in the IVF industry.